Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

First launch for inhaled smoking cessation product

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Nicotine nasal spray codevelopment agreement

Aug. 23, 1996

ImmuLogic receives SBIR grant for cocaine vaccine research

Aug. 16, 1996

Nicoderm CQ approved for OTC use

Aug. 16, 1996

Sanwa Kagaku reveals selectin inhibitors

Aug. 9, 1996

Nicotrol launched on U.S. market as OTC

July 26, 1996

Data on withdrawal from benzodiazepine treatment

July 19, 1996

FDA approves Nicotrol for OTC marketing

July 12, 1996

Alza/HMR and Ciba-Geigy resolve nicotine patch patent disputes

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...